Carvistar 3.125 Tablet
By Carvistar
Rx
15 Tablet in a Strip

Composition
Carvedilol(3.125mg)

Manufacturer - Lupin Ltd
Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India

Expires on or after
March, 2026

liver
When using Carvistar 3.125 Tablet, it is important to be cautious if you have liver disease. Dose adjustment of this tablet may be necessary in such cases, so make sure to consult your doctor before taking it. It is not advised to use Carvistar 3.125 Tablet if you have severe liver disease. Always prioritize your liver health and seek medical advice if needed.

kidney
Carvistar 3.125 Tablet is safe for use in patients with kidney disease. No dose adjustment is needed, but inform your doctor if you have kidney issues. Regular blood pressure monitoring is advised for potential dose adjustments.

alcohol
It is not safe to consume alcohol along with Carvistar 3.125 Tablet as it may have adverse effects.

driving
Carvistar 3.125 Tablet may reduce alertness, cause vision issues, or induce drowsiness. Avoid driving if you experience these effects.

pregnancy
Carvistar 3.125 Tablet may not be safe during pregnancy as animal studies have shown potential harm to the developing baby. Your doctor will consider the benefits and risks before prescribing it to you. Please consult your doctor before use.

breastfeeding
Carvistar 3.125 Tablet is considered safe for breastfeeding mothers. Existing data indicates no significant risk to infants, making it a likely option for nursing mothers.
Habit Forming | No |
Chemical Class | Carbazole & propanol derivative |
Therapeutic Class | CARDIAC |
Action Class | Alpha & beta blocker |
₹53.4
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024